David McWilliams Insider Profile
4 Followers
David McWilliams, Director at Greenwich LifeSciences, holds 620.30K shares in Greenwich LifeSciences (Ticker: GLSI), holds 0.00 shares in Acer Therapeutics (Ticker: ACER). Most recently, David McWilliams Bought ― shares of Greenwich LifeSciences on Dec 16, 2021 for an estimated value of $5.51K.
David McWilliams's Trading History
| GLSIGreenwich LifeSciences | Dec 16, 2021 | Director | Informative Buy | 5.51K | $9.98M | |
| ACERAcer Therapeutics | ― | ― | ― | $0.00 |
You May Also Like
David McWilliams insider profile FAQ
What is the percentage of profitable transactions made by David McWilliams?
The percentage of profitable transactions made by David McWilliams is 67%.
What is the average return per transaction made by David McWilliams?
The average return per transaction made by David McWilliams is 418.10%.
What stocks does David McWilliams hold?
David McWilliams holds: GLSI, ACER stocks.
What was David McWilliams’s latest transaction?
David McWilliams’s latest transaction was an Informative Buy of $5.51K.
What was David McWilliams's most profitable transaction?
David McWilliams’s most profitable transaction was an Informative Buy of GLSI stock on September 29, 2020. The return on the trade was 750.40%.
What is David McWilliams's role in Greenwich LifeSciences?
David McWilliams's role in Greenwich LifeSciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
